Therefore, we could suppose that the tissues most affected in CLSD are susceptible to variations in SEC23A levels or may have an insufficient expression of SEC23B or elevated SAR1B expression. The gene discussed is SAR1B; the disease is craniolenticulosutural dysplasia.